More Metabolic Abnormality Among Normal-Weight Minorities

Share this content:
More Metabolic Abnormality Among Normal-Weight Minorities
More Metabolic Abnormality Among Normal-Weight Minorities

WEDNESDAY, April 5, 2017 (HealthDay News) -- Racial/ethnic minority groups have a significantly higher prevalence of metabolic abnormality but normal weight (MAN) than whites, according to a study published online April 4 in the Annals of Internal Medicine.

Unjali P. Gujral, Ph.D., from Emory University in Atlanta, and colleagues conducted a cross-sectional analysis involving participants in the Multi-Ethnic Study of Atherosclerosis and in the Mediators of Atherosclerosis in South Asians Living in America study. They estimated the prevalence of two or more cardiometabolic abnormalities among normal-weight participants.

The researchers found that the prevalence of MAN was 21 percent in 846 whites, 32.2 percent in 323 Chinese-Americans, 31.1 percent in 334 African-Americans, 38.5 percent in 252 Hispanics, and 43.6 percent in 195 South Asians. The racial/ethnic differences were not explained by adjustment for demographic, behavioral, and ectopic body fat measures. For the equivalent MAN prevalence at a body mass index (BMI) of 25 kg/m² in whites, the corresponding BMI values were 22.9, 21.5, 20.9, and 19.6 kg/m² in African-Americans, Hispanics, Chinese-Americans, and South Asians, respectively, after adjustment for age, sex, and race/ethnicity-BMI interaction.

"Using a BMI criterion for overweight to screen for cardiometabolic risk may result in a large proportion of racial/ethnic minority groups being overlooked," the authors write.

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Approves Actemra to Treat Giant Cell Arteritis

FDA Approves Actemra to Treat Giant Cell Arteritis

New indication provides the first FDA-approved therapy specific to this type of vasculitis

Trends in Teen Binge Drinking Still Raise Concerns

Trends in Teen Binge Drinking Still Raise Concerns

Even though frequent binge drinking among adolescents has dropped in past 25 years

ATS: First Abx Rx Doesn't Work for 25 of Pneumonia Cases

ATS: First Abx Rx Doesn't Work for ~25% ...

One in four adult patients do not respond to initial prescription of antibiotic treatment

is free, fast, and customized just for you!

Already a member?

Sign In Now »